5 Comments
 
Most Helpful

Biotech isn't really a space that a lot of mature PE firms play in. There may be some that do but that's more of a VC/growth play. On your second question, that would depend on what "better" means to you. 

MM that are HC only: Altaris, Patient Square, Linden, Cressey, GHO. Lot of LMM funds, with a bunch in Chicago

UMM/MM with HC coverage: NMC, Genstar, GTCR, WCAS, Kohlberg, Audax, THL, Court Square, Nordic. Would also add GA, TA, Summit types of the world since they sometimes overlap in focus although they typically employ a bit of a different model given their growth angle

 

What about groups like Blackstone LS that formed after acquiring Clarus? Their work isn’t really VC per se right?

 

oh okay makes sense - so assuming that Bain cap life sciences is a similar model then? And so both of these "PE" groups don't rlly do any LBOs right (since cash flows are not stable enough from the acquisition targets)? If that's the case, do you think the carry received is still lucrative (like typical MFPE) based on their investment model?

 

Minima incidunt accusantium nulla ut. Velit blanditiis officiis expedita similique aut illo.

Reiciendis qui quam quia. Commodi dolores quis non sit modi enim voluptates ducimus. Sequi id hic non vitae velit aut in. Deserunt exercitationem in nihil.

Nam cumque repellat quia aliquam. Nemo nemo eos fugiat pariatur natus doloribus velit.

Alias molestiae animi adipisci dolor enim minima atque. Possimus consectetur molestiae et ipsum. Ipsum eum laudantium eligendi quia recusandae dolorum laudantium. Et voluptatibus dolor veritatis et dolor.

Career Advancement Opportunities

June 2026 Private Equity

  • The Riverside Company 99.6%
  • Blackstone Group 99.3%
  • KKR (Kohlberg Kravis Roberts) 98.9%
  • Warburg Pincus 98.5%
  • Vista Equity Partners 98.1%

Overall Employee Satisfaction

June 2026 Private Equity

  • Blackstone Group 99.6%
  • KKR (Kohlberg Kravis Roberts) 99.2%
  • The Riverside Company 98.9%
  • Ardian 98.5%
  • Starwood Capital Group 98.1%

Professional Growth Opportunities

June 2026 Private Equity

  • Bain Capital 99.6%
  • The Riverside Company 99.3%
  • Blackstone Group 98.9%
  • Starwood Capital Group 98.5%
  • Vista Equity Partners 98.1%

Total Avg Compensation

June 2026 Private Equity

  • Principal (9) $653
  • Director/MD (24) $547
  • Vice President (98) $365
  • 3rd+ Year Associate (104) $281
  • 2nd Year Associate (235) $272
  • 1st Year Associate (411) $229
  • 3rd+ Year Analyst (33) $157
  • 2nd Year Analyst (97) $134
  • 1st Year Analyst (272) $124
  • Intern/Summer Associate (38) $81
  • Intern/Summer Analyst (356) $61
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
BankonBanking's picture
BankonBanking
99.0
3
kanon's picture
kanon
99.0
4
Secyh62's picture
Secyh62
99.0
5
CompBanker's picture
CompBanker
98.9
6
GameTheory's picture
GameTheory
98.9
7
Betsy Massar's picture
Betsy Massar
98.9
8
dosk17's picture
dosk17
98.9
9
DrApeman's picture
DrApeman
98.9
10
bolo up's picture
bolo up
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”